Pre-Open Movers 2/25:Progenics Pharma (PGNX) Jumps On FDA Approval, Netgear (NTGR) Down on Results - Street Insider

Sign Up | Log In | What is SocialPicks?

Please sign up for SocialPicks site access - it's free!

Pre-Open Movers 2/25:Progenics Pharma (PGNX) Jumps On FDA Approval, Netgear (NTGR) Down on Results
Apr 25, 2008 01:31 PM UTC

Street Insider

Return	Risk
+9.67%	MID

Tracked Blogger

Profile & Performance

Subscribe to author

Symbol	Sentiment	Start	Return	Closed
NTGR	n/a
PGNX	n/a
WYE	n/a

Via StreetInsider.com News Articles:

StreetInsider.com Pre-Open Movers:

Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) 23% HIGHER; Progenics and Wyeth (NYSE: WYE) announced that the FDA has approved RELISTOR subcutaneous injection for the treatment of opioid-induced constipation in patients with advanced illness who are receiving palliative care, when response to laxative therapy has not been sufficient.

ISIS Pharmaceuticals Inc. (Nasdaq: ISIS) 23% LOWER; The FDA has provided guidance regarding approval requirements for mipomersen. The FDA has indicated that reduction of LDL-cholesterol is an acceptable surrogate endpoint for accelerated approval of mipomersen for use in patients with homozygous familial hypercholesterolemia (hoFH). The FDA will require data from two

Read the rest of original post »

Add Comment

Be the first to comment on this story and earn 2 points.

Your Comment

IN THE PRESS

None of the information contained on SocialPicks.com constitutes a recommendation by SocialPicks or its users that any particular security, portfolio of securities, transaction, or investment strategy is suitable for any specific person. SocialPicks is not responsible for the posts, discussions, and recommendations of the users on the Site. SocialPicks does not provide investment advice. You must make your own independent decisions regarding any security, portfolio of securities, transaction, or investment strategy mentioned on the website. SocialPicks' users' past results are not necessarily indicative of future performance. Neither SocialPicks nor any of its users guarantees any specific outcome or profit, and you should be aware of the real risk of loss in following any strategy or investments discussed on the website. You understand and agree that you use the Site and Services at your own discretion and risk and that you will be solely responsible for any damages that arise from such use. Before acting on any information contained on the website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.